Parties d'ouvrages collectifs (1)
Articles dans des revues avec comité de lecture (16)
1.
Goldrat, O., De Cooman, M., Mailliez, A., Delbaere, A., D'Orazio, E., Demeestere, I., & Decanter, C. (2022). Efficacy and safety of controlled ovarian hyperstimulation with or without letrozole for fertility preservation in breast cancer patients: A multicenter retrospective study. European journal of cancer, 174, 134-141. doi:10.1016/j.ejca.2022.07.0173.
Arecco, L., Blondeaux, E., Bruzzone, M., Ceppi, M., Latocca, M. M., Marrocco, C., Boutros, A., Spagnolo, F., Razeti, M. G., Favero, D., Spinaci, S., Condorelli, M., Massarotti, C., Goldrat, O., Del Mastro, L., Demeestere, I., & Lambertini, M. (2022). Safety of fertility preservation techniques before and after anticancer treatments in young women with breast cancer: a systematic review and meta-analysis. Human reproduction. doi:10.1093/humrep/deac0354.
Condorelli, M., Sens, M., Goldrat, O., Delbaere, A., Racapé, J., Lambertini, M., & Demeestere, I. (2022). A retrospective study evaluating the impact of scattering radiation from imaging procedures on oocyte quality during ovarian stimulation for fertility preservation in young breast cancer patients. Breast cancer research and treatment. doi:10.1007/s10549-021-06489-w5.
Rothé, F., Lambertini, M., Goldrat, O., Maetens, M., Bareche, Y., Blanc, J., Rouas, G., Larsimont, D., Sotiriou, C., Ignatiadis, M., & Demeestere, I. (2021). Circulating Tumor DNA to Interrogate the Safety of Letrozole-Associated Controlled Ovarian Stimulation for Fertility Preservation in Breast Cancer Patients. Frontiers in oncology, 11, 686625. doi:10.3389/fonc.2021.6866256.
Kteily, K., Pening, D., Diaz Vidal, P., Devos, M., Dechene, J., Op De Beeck, A., Botteaux, A., Janssens, S., Van den Abbeel, E., Goldrat, O., Delbaere, A., & Demeestere, I. (2021). Risk of contamination of semen, vaginal secretions, follicular fluid and ovarian medulla with SARS-CoV-2 in patients undergoing ART. Human reproduction. doi:10.1093/humrep/deab2557.
Bonardi, B. B., Massarotti, C., Bruzzone, M., Goldrat, O., Mangili, G., Anserini, P., Spinaci, S., Arecco, L., Del Mastro, L., Ceppi, M., Demeestere, I., & Lambertini, M. (2020). Efficacy and Safety of Controlled Ovarian Stimulation With or Without Letrozole Co-administration for Fertility Preservation: A Systematic Review and Meta-Analysis. Frontiers in oncology, 10, 574669. doi:10.3389/fonc.2020.5746698.
Goldrat, O., Van Den Steen, G., Gonzalez-Merino, E., Dechene, J., Gervy, C., Delbaere, A., Devreker, F., De Maertelaer, V., & Demeestere, I. (2019). Letrozole-associated controlled ovarian hyperstimulation in breast cancer patients versus conventional controlled ovarian hyperstimulation in infertile patients: Assessment of oocyte quality related biomarkers. Reproductive Biology and Endocrinology, 17(1), 3. doi:10.1186/s12958-018-0443-x9.
Lambertini, M., Goldrat, O., Ferreira, A. R., Dechene, J., Abdel Azim, H. H., Désir, J., Delbaere, A., T'Kint De Roodenbeke, M.-D., de Azambuja, E., Ignatiadis, M., & Demeestere, I. (2017). Reproductive potential and performance of fertility preservation strategies in BRCA-mutated breast cancer patients. Annals of oncology. doi:10.1093/annonc/mdx63910.
Lambertini, M., Goldrat, O., Toss, A., Abdel Azim, H. H., Peccatori, F. A., Ignatiadis, M., Del Mastro, L., & Demeestere, I. (2017). Fertility and pregnancy issues in BRCA-mutated breast cancer patients. Cancer treatment reviews, 59, 61-70. doi:10.1016/j.ctrv.2017.07.00111.
Lambertini, M., Goldrat, O., Clatot, F., Demeestere, I., & Awada, A. (2017). Controversies about fertility and pregnancy issues in young breast cancer patients: current state of the art. Current opinion in oncology, 29(4), 243-252. doi:10.1097/CCO.0000000000000380